You are here : Home > News Archive > CARBOGEN AMCIS AG Attends the Ev...
CARBOGEN AMCIS AG Attends the Event “Delivering a Potent and High Potent Manufacturing Strategy”

10-11 May 2011 Munich, Germany

2 May 2011

BUBENDORF, Switzerland (May 2, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is attending the 2nd biannual event entitled “Delivering a Potent and High Potent Manufacturing Strategy”, on May 10-11 in Munich, Germany. The event is focused on the production and up-scaling of Highly Potent APIs and has been organized by NextLevel Pharma.

 

CARBOGEN AMCIS will present its High Potency services spanning from process research and development of Highly Potent APIs (HPAPIs) to large-scale manufacturing and life cycle management. CARBOGEN AMCIS recently announced the successful containment performance validation of its commercial facility for multi-purpose production of HPAPIs located on the site of its parent company, Dishman Pharmaceuticals and Chemicals Ltd., in Ahmedabad, India.

 

During the conference, Mr Maarten Prause, industrial hygienist, CARBOGEN AMCIS will give a presentation entitled: “Understanding the implications of Risk-Based Manufacture of Pharmaceutical Products (RiskMaPP)” on Wednesday, May 11th starting at 10:50 am.

 

###

 

CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.

 

Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. Dishman Group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, China and India.

 

NextLevel Pharma (www.nextlevelpharma.com) is a leading, strategic business information and opportunity provider for the international life sciences industry.

News
21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

14 July 2016
CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection


Events
World ADC San Diego

CPhI WW